Key result
A review of antihypertensive combination therapy highlights the effects of angiotensin-converting enzyme inhibitors and calcium antagonists on microcirculation and endothelial dysfunction.
Why the study?
Does the combination of angiotensin-converting enzyme inhibitors and calcium antagonists improve microcirculation and endothelial dysfunction in patients with arterial hypertension?
Does the combination of angiotensin-converting enzyme inhibitors and calcium antagonists improve microcirculation and endothelial dysfunction in patients with arterial hypertension?
This review highlights the pharmacotherapeutic benefits of combining ACE inhibitors and calcium antagonists for treating arterial hypertension, particularly regarding vascular parameters.
Answers are grounded in this paper and cite their sources.
May suggest microcirculatory benefits of ACEI-CCB combinations in hypertension; hypothesis-generating and requires prospective RCTs before practice change.
The paper focuses on the justification for preferential administration of antihypertensive combination therapy. Pharmacotherapeutic features of starting the treatment with a combination of angiotensin-converting enzyme inhibitors (ACEI) and calcium antagonists (AC) are reviewed. The authors also present the latest evidence on the ACEI/AC combination effects on such vascular parameters as microcirculation and endothelial dysfunction.
No takes yet. Share an insight, caveat, or question.
Кириченко et al. (2014) conducted a review in Arterial hypertension. Angiotensin-converting enzyme inhibitors (ACEI) and calcium antagonists (AC) combination was evaluated on Vascular parameters (microcirculation and endothelial dysfunction). A review of antihypertensive combination therapy highlights the effects of angiotensin-converting enzyme inhibitors and calcium antagonists on microcirculation and endothelial dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: